Support MS Research

Sign Up to eNewsletter

Be the first to receive the latest news on MS Research.

 

News

Showing 1 to 10 of 663

Study of optic nerve cells highlights avenues for myelin regeneration

25th September, 2014

The optic nerve connects the nerve cell receptors of the eye with the brain and, in the human, contains about one million nerve fibres organised into parallel bundles. Despite its location, the optic

Read More

Largest global MS scientific meeting has record outcomes

23rd September, 2014

Nine thousand delegates converged on Boston USA in early September to attend the largest ACTRIMS-ECTRIMS meeting dedicated to MS research and clinical management around the world. ACTRIMS and ECTRIMS are

Read More

Five new Incubator grants for 2014

23rd September, 2014

Each year MS Research Australia welcomes two rounds of applications for Incubator Grant projects. Incubator grants provide seed funding for the early stages of new research efforts, with the aim of

Read More

Getting involved in research into MS

23rd September, 2014

The MS Research Australia Clinical Trials Network website provides updated information on the various trials available and the recruiting criteria, visit www.mstrials.org.au Summary of some of the studies

Read More

Finding the answers for Progressive MS

23rd September, 2014

The International Progressive MS Alliance recently announced its first round of prestigious research grants to 22 investigators in nine countries. This first round of funding launches an ambitious program

Read More

Thank You Foundation 5 Million Plus

23rd September, 2014

Nine years ago, a small group of passionate individuals launched F5m (Foundation 5 million) from Wynard Park in Sydney. Their goal was to raise $5 million towards MS research into a cure for multiple

Read More

Experimental gene technology treatment shows promise for MS

22nd September, 2014

An Australian biotech company has published encouraging phase II clinical trial results for a novel genetic technology approach to treat relapsing MS

Read More

Updates on the next PBAC meeting: modified interferon beta being considered, and Lemtrada resubmission

16th September, 2014

A modified version of Interferon-beta1a, recently approved for the treatment of relapsing remitting MS by both the European Medicines Agency and the USA Food and Drug Authority, is currently being

Read More

First research studies launched in 9 countries as part of €22 million global effort to End Progressive MS

12th September, 2014

International Progressive MS Alliance established as worldwide collaborative with goal to find solutions and treatments for progressive MS The International Progressive MS Alliance has awarded its first

Read More

Australia becomes first country in Southern Hemisphere to join ambitious global MS research alliance

12th September, 2014

MS Research Australia has joined MS organisations in the USA, UK, Italy, Denmark, Spain and Canada in a global alliance to end progressive MS

Read More

Showing 1 to 10 of 663